Sector consensus Indivior PLC

Equities

Market Closed - London S.E. Other stock markets 11:35:15 2025-07-08 EDT			5-day change	1st Jan Change
1,128.00 ^GBX	-1.48%		+5.52%	+10.16%

09:05am	Indivior Appoints Vanessa Procter as Executive Vice President of Corporate Affairs, Effective July 7, 2025	CI
06-30	Indivior PLC(NasdaqGS:INDV) added to Russell 3000 Value Index	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Average Target P.	Ecart obj. / dr	Nbr of analysts
INDIVIOR PLC			GBX 14.6	-6.57%	5
MERCK KGAA			€159.88	+46.2%	16
KYOWA KIRIN CO., LTD.			JP¥2,540.91	+1.47%	11
HALOZYME THERAPEUTICS, INC.			US$67	+23.57%	8
YUHAN CORPORATION			₩144,375	+34.18%	16
SK BIOPHARMACEUTICALS CO., LTD.			₩138,250	+49.62%	16
BETTA PHARMACEUTICALS CO., LTD.			CN¥64.54	+14.8%	2
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	-	-	-	-	-
SUPERNUS PHARMACEUTICALS, INC.			US$39	+24.01%	5
SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.	-	-	CN¥37.6	+14.63%	1
YOUCARE PHARMACEUTICAL GROUP CO., LTD.	-	-	CN¥28	+11.78%	1
CHANGCHUN BCHT BIOTECHNOLOGY CO.			CN¥28	+33.02%	2
KISSEI PHARMACEUTICAL CO., LTD.			JP¥4,675	+17.31%	4
HK INNO.N CORPORATION			₩60,333.33	+41.79%	12
CORMEDIX INC.			US$19.14	+67.63%	7
OSCOTEC INC.	-	-	₩59,000	+96.34%	1
Average			27,308.8	+31.32%	7
Weighted average by Cap.			17,536.44	+36.42%	13